Circulating tumor cell and circulating tumor DNA assays reveal complementary information for patients with metastatic urothelial cancer

HJ Chalfin, SA Glavaris, MA Gorin, MR Kates… - European urology …, 2021 - Elsevier
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …
被引用次数：35 相关文章

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

HJ Chalfin, SA Glavaris, MA Gorin… - European Urology …, 2021 - profiles.wustl.edu
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …

[引用][C] Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

HJ Chalfin, SA Glavaris, MA Gorin, MR Kates… - European Urology …, 2021 - cir.nii.ac.jp
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary
Information for Patients with Metastatic Urothelial Cancer | CiNii Research CiNii 国立情報学 …

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

HJ Chalfin, SA Glavaris, MA Gorin… - European urology …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

HJ Chalfin, SA Glavaris… - European …, 2021 - euoncology.europeanurology.com
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

HJ Chalfin, SA Glavaris, MA Gorin… - European Urology …, 2021 - pure.johnshopkins.edu
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer.

HJ Chalfin, SA Glavaris, MA Gorin… - European Urology …, 2019 - europepmc.org
Despite considerable advances in the management of urothelial carcinoma (UC), better risk
stratification and enhanced detection of minimal residual disease are still urgent priorities to …